Avecho Biotechnology Limited (OEZ) Income Statement
Avecho Biotechnology Limited Income Statement
Last quarter (Q2 2026), Avecho Biotechnology Limited's total revenue was $59.60K, a decrease of 80.91% from the same quarter last year. In Q2, Avecho Biotechnology Limited's net income was $-1.92M. See Avecho Biotechnology Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.24M | $ 1.13M | $ 473.55K | $ 1.13M | $ 793.60K | |
| $ 751.29K | $ 671.93K | $ -43.80K | $ 793.12K | $ 507.94K | |
| $ 6.76M | $ 5.63M | $ 4.55M | $ 3.86M | $ 5.06M | |
| Depreciation and Amortization | $ 137.09K | $ 144.88K | $ 178.69K | $ 230.35K | $ 428.59K |
| $ -5.87M | $ -2.92M | $ -3.24M | $ -2.11M | $ -2.98M | |
| $ -6.00M | $ -4.96M | $ -4.59M | $ -3.06M | $ -4.55M | |
| $ -408.21K | $ 1.84M | $ 77.06K | $ 98.55K | $ 1.13M | |
| $ -6.41M | $ -3.12M | $ -4.51M | $ -2.96M | $ -4.54M | |
| $ -4.42M | $ -3.12M | $ -3.44M | $ -2.34M | $ -3.42M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.00 | $ -0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Diluted EPS | $ -0.00 | $ -0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Weighted Average Shares Outstanding | 3.27B | 3.12B | 2.27B | 1.80B | 1.80B |
| Weighted Average Shares Outstanding (Diluted) | 3.27B | 3.12B | 2.27B | 1.84B | 1.80B |
Currency in AUD
